Cash Flow Statement

Amortization Amortization Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Others

Incannex Healthcare (IXHL) Capital Expenditures (2022 - 2025)

Incannex Healthcare's Capital Expenditures history spans 3 years, with the latest figure at $4000.0 for Q4 2025.

On a quarterly basis, Capital Expenditures changed N/A to $4000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $6000.0, a N/A change, with the full-year FY2025 number at $8000.0, down 97.11% from a year prior.
Capital Expenditures hit $4000.0 in Q4 2025 for Incannex Healthcare, up from $2000.0 in the prior quarter.
Over the last five years, Capital Expenditures for IXHL hit a ceiling of $221000.0 in Q3 2023 and a floor of -$6000.0 in Q1 2024.
Historically, Capital Expenditures has averaged $47166.7 across 3 years, with a median of $3500.0 in 2024.